{"product_id":"arrs-opportunities-and-obligations","title":"ARRS Opportunities and Obligations in Imaging Patients with Alzheimer’s Disease 2025","description":"\u003cdiv class=\"elementor-element elementor-element-371ff86 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"371ff86\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"elementor-widget-container\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003ch1 class=\"product-title product_title entry-title\"\u003eARRS Opportunities and Obligations in Imaging Patients with Alzheimer’s Disease 2025\u003c\/h1\u003e\n\u003ch3\u003e\n\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e Aug 2025\u003c\/h3\u003e\n\u003cbr\u003e \u003cbr\u003e\u003ch4\u003eAnti-amyloid targeting disease-modifying therapies for Alzheimer’s disease present an exciting opportunity to dramatically impact the lives of patients with Alzheimer’s dementia. The imaging impact is already formidable, with a significant rise in MRI volume. Amyloid PET volumes have also skyrocketed following a positive reimbursement decision for patient selection and treatment surveillance.\u003c\/h4\u003e\n\u003cbr\u003e \u003cbr\u003e\u003ch2\u003eLearning Outcomes and Modules\u003c\/h2\u003e\n\u003cbr\u003eAfter completing this course, the learner should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIdentify the challenges and opportunities of AD in the era of DMT.\u003c\/li\u003e\n\u003cli\u003eDiscuss the benefits and risks of amyloid targeting therapies.\u003c\/li\u003e\n\u003cli\u003eDiscuss clinical implications of ARIA grading and multidisciplinary communication.\u003c\/li\u003e\n\u003cli\u003eRecognize the role of molecular imaging in the dementia imaging pathway.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSpeakers and Lectures\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMultimodal Dementia Imaging with Emphasis on Alzheimer’s Disease and ARIA Cases—\u003cem\u003eSuzie Bash\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eEnterprise Workflow Optimization for Alzheimer’s Screening and ARIA Surveillance—\u003cem\u003eLawrence Tanenbaum\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eRadiology Perspective: Multidisciplinary Approach to Challenging Cases—\u003cem\u003eTammie Benzinger\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954510729314,"sku":"MED-AMB05030","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ARRS-Opportunities-and-Obligations-in-Imaging-Patients-with-Alzheimers-Disease-2025.webp?v=1779378590","url":"https:\/\/meducourse.com\/products\/arrs-opportunities-and-obligations","provider":"Meducourse","version":"1.0","type":"link"}